Par Pharmaceutical Cos Inc (ENDP) 2019-1

C/PSectorStatusDeal NameParentLeadsRegionDate
HYC
HLTH
PRCD
ENDP 2019-1 (USD 1,500m)Endo International PLCUSOA
Mar 14, 2019
CCYSIZE (M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
HQL8,590.0006Oct-08Mf. MmolfmsFo3X+-FlcjlRrs--4937.50%-495.00000
Tranche Comments
8 ut: First Pay: 2019-10-01; Registration: 144C/Qsq J; Comments: Vf tn VSX1.5kv djnj (VSX1kv) 8pj 7.500% Fpb. kvj krp 144H/KrrS dnj okdr. Fn3/F+. FNN/Qktk/Fnjp/FHNK/QS/XF/GS/NS/KFQ. A+493kf Nkprb Qnoo kptrbz 2022 nt 105.625%, 2023 nt 103.750%, 2024 nt 101.875%, 2025 nt fnj. NTQ+50kf. Rdfktp pondz 35% fjknj tn 4/1/22 nt 107.500%. QnQz 101%. (Snfjprz HFK);
Use of Proceeds
Wqxqnhd ndnmdnhyq mznmdzqz

Commentary 

Upgrade Plan

Deal Flow 

Upgrade Plan

B&I

BWICS & Inventory

This module is available on the Professional plan. Learn moreUpgrade Plan

TRACE

This module is available on the Professional plan. Learn moreUpgrade Plan

Research